Nantahala Capital Management’s ADC Therapeutics ADCT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $6.07M | Buy |
+2,266,289
| New | +$6.07M | 0.24% | 66 |
|
|
2023
Q4 | – | Sell |
-257,162
| Closed | -$231K | – | 112 |
|
|
2023
Q3 | $231K | Sell |
257,162
-582,838
| -69% | -$523K | 0.02% | 100 |
|
|
2023
Q2 | $1.81M | Hold |
840,000
| – | – | 0.17% | 68 |
|
|
2023
Q1 | $1.64M | Buy |
840,000
+596,710
| +245% | +$1.16M | 0.13% | 70 |
|
|
2022
Q4 | $934K | Buy |
+243,290
| New | +$934K | 0.06% | 76 |
|